UniProt ID | RGPS2_HUMAN | |
---|---|---|
UniProt AC | Q86X27 | |
Protein Name | Ras-specific guanine nucleotide-releasing factor RalGPS2 | |
Gene Name | RALGPS2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 583 | |
Subcellular Localization | Cytoplasm. Cell membrane. Associates with membranes through the PH domain.. | |
Protein Description | Guanine nucleotide exchange factor for the small GTPase RALA. May be involved in cytoskeletal organization. May also be involved in the stimulation of transcription in a Ras-independent fashion (By similarity).. | |
Protein Sequence | MDLMNGQASSVNIAATASEKSSSSESLSDKGSELKKSFDAVVFDVLKVTPEEYAGQITLMDVPVFKAIQPDELSSCGWNKKEKYSSAPNAVAFTRRFNHVSFWVVREILHAQTLKIRAEVLSHYIKTAKKLYELNNLHALMAVVSGLQSAPIFRLTKTWALLSRKDKTTFEKLEYVMSKEDNYKRLRDYISSLKMTPCIPYLGIYLSDLTYIDSAYPSTGSILENEQRSNLMNNILRIISDLQQSCEYDIPMLPHVQKYLNSVQYIEELQKFVEDDNYKLSLKIEPGTSTPRSAASREDLVGPEVGASPQSGRKSVAAEGALLPQTPPSPRNLIPHGHRKCHSLGYNFIHKMNTAEFKSATFPNAGPRHLLDDSVMEPHAPSRGQAESSTLSSGISIGSSDGSELSEETSWPAFERNRLYHSLGPVTRVARNGYRSHMKASSSAESEDLAVHLYPGAVTIQGVLRRKTLLKEGKKPTVASWTKYWAALCGTQLFYYAAKSLKATERKHFKSTSNKNVSVIGWMVMMADDPEHPDLFLLTDSEKGNSYKFQAGNRMNAMLWFKHLSAACQSNKQQVPTNLMTFE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | DLMNGQASSVNIAAT CCCCCCCCCCEEEEE | 27.25 | 20068231 | |
10 | Phosphorylation | LMNGQASSVNIAATA CCCCCCCCCEEEEEC | 23.38 | 20068231 | |
21 | Phosphorylation | AATASEKSSSSESLS EEECCCCCCCCCCCC | 31.25 | 23403867 | |
22 | Phosphorylation | ATASEKSSSSESLSD EECCCCCCCCCCCCH | 49.29 | 23403867 | |
23 | Phosphorylation | TASEKSSSSESLSDK ECCCCCCCCCCCCHH | 45.26 | 26055452 | |
24 | Phosphorylation | ASEKSSSSESLSDKG CCCCCCCCCCCCHHH | 32.90 | 23403867 | |
26 | Phosphorylation | EKSSSSESLSDKGSE CCCCCCCCCCHHHHH | 34.81 | 25849741 | |
28 | Phosphorylation | SSSSESLSDKGSELK CCCCCCCCHHHHHHH | 46.70 | 23403867 | |
32 | Phosphorylation | ESLSDKGSELKKSFD CCCCHHHHHHHHHHC | 45.56 | 23403867 | |
37 | Phosphorylation | KGSELKKSFDAVVFD HHHHHHHHHCEEEEE | 27.11 | 30278072 | |
79 | Ubiquitination | ELSSCGWNKKEKYSS HHHCCCCCCHHHCCC | 30.70 | 23000965 | |
83 | Ubiquitination | CGWNKKEKYSSAPNA CCCCCHHHCCCCCCE | 60.35 | 23000965 | |
84 | Phosphorylation | GWNKKEKYSSAPNAV CCCCHHHCCCCCCEE | 14.67 | 28258704 | |
86 | Phosphorylation | NKKEKYSSAPNAVAF CCHHHCCCCCCEEHH | 44.66 | 28258704 | |
94 | Phosphorylation | APNAVAFTRRFNHVS CCCEEHHHHCCCCHH | 15.93 | 28258704 | |
101 | Phosphorylation | TRRFNHVSFWVVREI HHCCCCHHHHHHHHH | 13.07 | 28258704 | |
122 | Phosphorylation | KIRAEVLSHYIKTAK HHHHHHHHHHHHHHH | 21.30 | 28258704 | |
124 | Phosphorylation | RAEVLSHYIKTAKKL HHHHHHHHHHHHHHH | 10.75 | 20068231 | |
158 | Phosphorylation | PIFRLTKTWALLSRK CHHHHHHHHHHHCCC | 15.67 | - | |
175 | Phosphorylation | TTFEKLEYVMSKEDN CHHHHHHHHHCCCHH | 16.34 | 23663014 | |
178 | Phosphorylation | EKLEYVMSKEDNYKR HHHHHHHCCCHHHHH | 23.89 | 23663014 | |
183 | Phosphorylation | VMSKEDNYKRLRDYI HHCCCHHHHHHHHHH | 15.14 | 23663014 | |
191 | Phosphorylation | KRLRDYISSLKMTPC HHHHHHHHHCCCCCC | 24.32 | 24719451 | |
259 | Phosphorylation | MLPHVQKYLNSVQYI CHHHHHHHHHHHHHH | 8.27 | 22817900 | |
265 | Phosphorylation | KYLNSVQYIEELQKF HHHHHHHHHHHHHHH | 14.24 | 22817900 | |
271 | Ubiquitination | QYIEELQKFVEDDNY HHHHHHHHHHHCCCE | 65.09 | - | |
278 | Phosphorylation | KFVEDDNYKLSLKIE HHHHCCCEEEEEEEC | 21.94 | - | |
279 | Ubiquitination | FVEDDNYKLSLKIEP HHHCCCEEEEEEECC | 37.54 | 23000965 | |
281 | Phosphorylation | EDDNYKLSLKIEPGT HCCCEEEEEEECCCC | 24.38 | 24719451 | |
283 (in isoform 1) | Ubiquitination | - | 41.47 | 21906983 | |
283 | Ubiquitination | DNYKLSLKIEPGTST CCEEEEEEECCCCCC | 41.47 | 21906983 | |
283 | Ubiquitination | DNYKLSLKIEPGTST CCEEEEEEECCCCCC | 41.47 | 23000965 | |
288 | Phosphorylation | SLKIEPGTSTPRSAA EEEECCCCCCCCCCC | 39.89 | 29255136 | |
289 | Phosphorylation | LKIEPGTSTPRSAAS EEECCCCCCCCCCCC | 42.18 | 29255136 | |
290 | Phosphorylation | KIEPGTSTPRSAASR EECCCCCCCCCCCCH | 23.66 | 25849741 | |
293 | Phosphorylation | PGTSTPRSAASREDL CCCCCCCCCCCHHHC | 29.41 | 23927012 | |
296 | Phosphorylation | STPRSAASREDLVGP CCCCCCCCHHHCCCC | 35.60 | 19664994 | |
308 | Phosphorylation | VGPEVGASPQSGRKS CCCCCCCCCCCCCCC | 19.97 | 19664994 | |
311 | Phosphorylation | EVGASPQSGRKSVAA CCCCCCCCCCCCHHH | 43.90 | 30266825 | |
315 | Phosphorylation | SPQSGRKSVAAEGAL CCCCCCCCHHHCCCC | 18.67 | 29255136 | |
326 | Phosphorylation | EGALLPQTPPSPRNL CCCCCCCCCCCCCCC | 34.92 | 29255136 | |
329 | Phosphorylation | LLPQTPPSPRNLIPH CCCCCCCCCCCCCCC | 37.38 | 19664994 | |
343 | Phosphorylation | HGHRKCHSLGYNFIH CCCHHCHHCCCHHHH | 32.72 | 23401153 | |
346 | Phosphorylation | RKCHSLGYNFIHKMN HHCHHCCCHHHHCCC | 16.52 | 23927012 | |
354 | Phosphorylation | NFIHKMNTAEFKSAT HHHHCCCHHHHHHCC | 24.86 | 27251275 | |
358 | Methylation | KMNTAEFKSATFPNA CCCHHHHHHCCCCCC | 30.59 | 115976155 | |
359 | Phosphorylation | MNTAEFKSATFPNAG CCHHHHHHCCCCCCC | 37.55 | 30266825 | |
361 | Phosphorylation | TAEFKSATFPNAGPR HHHHHHCCCCCCCCC | 46.87 | 23401153 | |
374 | Phosphorylation | PRHLLDDSVMEPHAP CCCCCCCCCCCCCCC | 24.03 | 29255136 | |
382 | Phosphorylation | VMEPHAPSRGQAESS CCCCCCCCCCCCCCC | 50.23 | 29255136 | |
420 | Phosphorylation | AFERNRLYHSLGPVT HHHHCCHHHHCCHHH | 6.02 | 21945579 | |
422 | O-linked_Glycosylation | ERNRLYHSLGPVTRV HHCCHHHHCCHHHHH | 22.82 | OGP | |
422 | Phosphorylation | ERNRLYHSLGPVTRV HHCCHHHHCCHHHHH | 22.82 | 21945579 | |
427 | Phosphorylation | YHSLGPVTRVARNGY HHHCCHHHHHHHCCH | 23.66 | 29255136 | |
441 | Phosphorylation | YRSHMKASSSAESED HHHHCCCCCCCCCCC | 21.21 | 28348404 | |
442 | Phosphorylation | RSHMKASSSAESEDL HHHCCCCCCCCCCCC | 38.13 | 28348404 | |
443 | Phosphorylation | SHMKASSSAESEDLA HHCCCCCCCCCCCCC | 33.29 | 28348404 | |
446 | Phosphorylation | KASSSAESEDLAVHL CCCCCCCCCCCCHHH | 35.81 | 28348404 | |
477 | Phosphorylation | LKEGKKPTVASWTKY HHCCCCCCCHHHHHH | 37.27 | - | |
511 | Phosphorylation | TERKHFKSTSNKNVS HHHHHHHCCCCCCEE | 35.80 | - | |
512 | Phosphorylation | ERKHFKSTSNKNVSV HHHHHHCCCCCCEEE | 36.59 | - | |
513 | Phosphorylation | RKHFKSTSNKNVSVI HHHHHCCCCCCEEEE | 53.55 | - | |
539 | Phosphorylation | HPDLFLLTDSEKGNS CCCEEEEECCCCCCE | 39.36 | 30576142 | |
546 | Phosphorylation | TDSEKGNSYKFQAGN ECCCCCCEEEECCCC | 38.07 | 30576142 | |
548 | Ubiquitination | SEKGNSYKFQAGNRM CCCCCEEEECCCCCC | 30.71 | - | |
548 | Malonylation | SEKGNSYKFQAGNRM CCCCCEEEECCCCCC | 30.71 | 26320211 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RGPS2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RGPS2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RGPS2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
1433Z_HUMAN | YWHAZ | physical | 28514442 | |
1433G_HUMAN | YWHAG | physical | 28514442 | |
CING_HUMAN | CGN | physical | 27173435 | |
KI13B_HUMAN | KIF13B | physical | 27173435 | |
GGYF2_HUMAN | GIGYF2 | physical | 27173435 | |
GGYF1_HUMAN | GIGYF1 | physical | 27173435 | |
CBY1_HUMAN | CBY1 | physical | 27173435 | |
LRFN1_HUMAN | LRFN1 | physical | 27173435 | |
NADK_HUMAN | NADK | physical | 27173435 | |
HDAC4_HUMAN | HDAC4 | physical | 27173435 | |
SI1L1_HUMAN | SIPA1L1 | physical | 27173435 | |
NGAP_HUMAN | RASAL2 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293; SER-296; SER-308;THR-326 AND SER-329, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308; SER-311; THR-326AND SER-329, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-422, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-326; SER-329 ANDSER-343, AND MASS SPECTROMETRY. |